Chapter 47: LEVEL 14
The apartment was quiet at 11 PM.
I sat at my desk, surrounded by the detritus of three junior researchers' draft papers—each one marked up with my comments, each one significantly improved by my guidance. The "Teaching Excellence" mission chain had consumed most of my non-research hours for the past two weeks.
But it was worth it. More than worth it.
[MISSION CHAIN COMPLETE: 'TEACHING EXCELLENCE.' OBJECTIVE: MENTOR THREE JUNIOR RESEARCHERS TO SUCCESSFUL PUBLICATION SUBMISSION. STATUS: ALL THREE PAPERS SUBMITTED. REWARD: +350 XP.]
The notification triggered something deeper.
[LEVEL UP: 13 → 14. +15 IQ RESERVE POINTS (PERMANENT). +1 BASE IQ. TOTAL XP TO NEXT LEVEL: 0/1500. ONE LEVEL REMAINING FOR NZT-48 RECIPE UNLOCK.]
My hands were actually shaking.
Level 14. One level away from the goal I'd been chasing since I understood what the System could offer.
[EXPANDED NZT-48 PREVIEW UNLOCKED. DISPLAYING ADDITIONAL RECIPE INFORMATION...]
The System's display shifted, revealing details I hadn't seen before.
[NZT-48 SYNTHESIS REQUIREMENTS: - Primary compounds: 7 total - Controlled substances: 3 (DEA Schedule II-IV) - Specialized supplier compounds: 2 - Standard laboratory chemicals: 2 - Synthesis time: Approximately 8 weeks - Batch yield: 20 pills - Estimated cost per batch: $45,000 - Required equipment: Standard biochemistry lab + specialized distillation apparatus - Skill requirement: Molecular synthesis proficiency (HOST QUALIFIED)]
My excitement dimmed.
$45,000. For twenty pills. That was... significant.
I did the mental math. My savings had grown over the past year—careful budgeting, no major expenses—but I was sitting on maybe $30,000 liquid. Not enough.
And the controlled substances added another layer of complexity. DEA Schedule II-IV meant prescriptions, documentation, oversight. Getting those materials legitimately would require either a compelling research justification or access to existing pharmaceutical supplies.
This won't be easy.
[ADVISORY: FINANCIAL CONSTRAINTS IDENTIFIED. ALTERNATIVE PATHWAYS AVAILABLE. OPTION A: CONSULTING INCOME. OPTION B: PATENT LICENSING. OPTION C: HIGH-REWARD MISSIONS (NOTE: MAY CONFLICT WITH ETHICAL PARAMETERS). OPTION D: INSTITUTIONAL GRANT APPLICATION.]
I closed the display, leaning back in my chair.
The corporate consulting offer from months ago surfaced in my memory. I'd declined it quickly—too worried about compromising my independence, too focused on the Simmons response. But consulting fees for pharmaceutical companies could be substantial. Enough to close the funding gap.
Or...
Bernadette. Howard's girlfriend, newly promoted at her pharmaceutical company. She'd mentioned something about research collaborations, access to materials, industry connections. If I could find a legitimate research angle that justified the compounds I needed...
No. That's using a friend's relationship for personal gain. There has to be a cleaner way.
I got up from the desk, pacing my small living room.
The NZT recipe was so close I could taste it. Perfect recall. Perfect connection. The ability to see patterns that others missed, to solve problems that had seemed impossible, to become something more than human.
But at what cost?
[QUERY: HOST APPEARS CONFLICTED. CLARIFICATION REQUESTED.]
I want this, I thought at the System. I want it more than almost anything. But I won't compromise who I've become to get it.
[ETHICAL CONSTRAINTS NOTED. PATH EFFICIENCY REDUCED BY APPROXIMATELY 40%. HOWEVER: VIABLE OPTIONS REMAIN. CONSULTING INCOME IS LEGITIMATE. PATENT LICENSING IS LEGITIMATE. EXTENDING TIMELINE TO ACCUMULATE RESOURCES IS LEGITIMATE. RECOMMENDATION: PROCEED WITH INTEGRITY INTACT.]
It was the most human thing the System had ever said to me.
Proceed with integrity intact.
I could do that. I could find a way that didn't require selling out, that didn't compromise the person I'd built in this borrowed life.
Sleep didn't come easily.
I lay in bed staring at the ceiling, mind racing with calculations and possibilities.
The patent option had potential. My research had generated several innovations that weren't yet protected—efficiency improvements, synthesis techniques, optimization protocols. If I filed strategically, the licensing fees could accumulate over time.
Consulting was more immediate. One or two pharmaceutical advisory sessions could net $10-15,000. Enough to close the gap.
And there was the Simmons collaboration offer to consider. If that relationship developed into something genuine, it might open doors I couldn't access alone. MIT had resources. Connections. The kind of infrastructure that made expensive research possible.
Don't rush, I told myself. You've waited this long. A few more months won't kill you.
But the anticipation was a physical thing, coiling in my chest. One level away from NZT-48. One level away from becoming something more than I'd ever imagined possible.
[SLEEP DEBT ACCUMULATING. COGNITIVE EFFICIENCY WILL DECREASE IF REST IS NOT ACHIEVED. RECOMMENDATION: CEASE RUMINATION. PROBLEMS WILL REMAIN TOMORROW.]
Thanks for the advice.
I forced my eyes closed, tried to quiet my thoughts.
Tomorrow, the response paper would be one day closer to publication. Tomorrow, I'd start working on the patent applications. Tomorrow, I'd figure out the next step on the path to Level 15.
Tonight, I'd try to sleep.
It was a long time coming.
Want more? The story continues on Patreon!
If you can't wait for the weekly release, you can grab +10, +15, or +20 chapters ahead of time on my Patreon page. Your support helps me keep this System running!
Read ahead here: [ patreon.com/system_enjoyer ]